Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Feb;67(2):801-6.
doi: 10.1128/JVI.67.2.801-806.1993.

Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes

Affiliations
Comparative Study

Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes

A L Rothman et al. J Virol. 1993 Feb.

Abstract

The identification of the protein targets for dengue virus-specific T lymphocytes may be useful for planning the development of subunit vaccines against dengue. We studied the recognition by murine dengue virus-specific major histocompatibility complex class I-restricted, CD8+ cytotoxic T lymphocytes (CTL) of dengue virus proteins using recombinant vaccinia viruses containing segments of the dengue virus genome. CTL from H-2k mice recognized a single serotype-cross-reactive epitope on the nonstructural (NS) protein NS3. CTL from H-2b mice recognized a serotype-cross-reactive epitope that was localized to NS4a or NS4b. CTL from H-2d mice recognized at least three epitopes: a serotype-specific epitope on one of the structural proteins, a serotype-cross-reactive epitope on NS3, and a serotype-cross-reactive epitope on NS1 or NS2a. Our findings demonstrate the limited recognition of dengue virus proteins by CTL from three inbred mouse strains and the predominance of CTL epitopes on dengue virus nonstructural proteins, particularly NS3. Since human dengue virus-specific CTL show similar patterns of recognition, these findings suggest that nonstructural proteins should be considered in designing vaccines against dengue.

PubMed Disclaimer

References

    1. J Gen Virol. 1992 May;73 ( Pt 5):1115-23 - PubMed
    1. Yale J Biol Med. 1970 Apr;42(5):311-28 - PubMed
    1. Acta Virol. 1981 Jan;25(1):10-8 - PubMed
    1. J Immunol. 1983 Jan;130(1):463-70 - PubMed
    1. J Virol. 1984 Oct;52(1):223-30 - PubMed

Publication types